Investigación
Educación
Soluciones
Iniciar sesión
ES
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Centre for Trials Research,
College of Biomedical and Life Sciences,
Centre for Trials Research, College of Biomedical and Life Sciences
Grace Young has not added Biography.
If you are Grace Young and would like to personalize this page please email our Author Liaison for assistance.
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
BJU international Dec, 2016 | Pubmed ID: 27415448
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial.
Journal of clinical epidemiology Apr, 2018 | Pubmed ID: 29288137
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.
Journal of clinical epidemiology Sep, 2019 | Pubmed ID: 31170515
Anaesthetic-analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT.
Health technology assessment (Winchester, England) Jul, 2019 | Pubmed ID: 31304912
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
European urology Mar, 2020 | Pubmed ID: 31771797
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression.
BJU international Apr, 2020 | Pubmed ID: 31900963
Erratum to 'Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received' [European Urology 77 (2020) 320-330].
European urology Sep, 2020 | Pubmed ID: 32624282
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
Health technology assessment (Winchester, England) Aug, 2020 | Pubmed ID: 32773013
Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT.
Health technology assessment (Winchester, England) Sep, 2020 | Pubmed ID: 32902375
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
BJU international Sep, 2022 | Pubmed ID: 35373443
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
The New England journal of medicine Apr, 2023 | Pubmed ID: 36912538
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
NEJM evidence Apr, 2023 | Pubmed ID: 38320051
Cardiff University
Yuri Kriel1,
Andrzej Kwintowski1,
Krist Feka1,
Mark Windsor1,
Grace Young2,
Meegan Walker1,
Christopher D. Askew1,3
1VasoActive Research Group, School of Health, University of the Sunshine Coast,
2Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University,
3, Sunshine Coast Health Institute, Sunshine Coast Hospital and Health Service
Privacidad
Condiciones de uso
Políticas
Contáctenos
RECOMIENDE A LA BIBLIOTECA
BOLETINES de JoVE
JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Autores
Bibliotecarios
Acceso
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados